| BET bromodomain inhibition as a therapeutic strategy to target c-Myc JE Delmore, GC Issa, ME Lemieux, PB Rahl, J Shi, HM Jacobs, E Kastritis, ... Cell 146 (6), 904-917, 2011 | 3082 | 2011 |
| Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma JJ Keats, R Fonseca, M Chesi, R Schop, A Baker, WJ Chng, S Van Wier, ... Cancer cell 12 (2), 131-144, 2007 | 1210 | 2007 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1181 | 2009 |
| Genetics and cytogenetics of multiple myeloma: a workshop report R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ... Cancer research 64 (4), 1546-1558, 2004 | 934 | 2004 |
| Frequent translocation t (4; 14)(p16. 3; q32. 3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 M Chesi, E Nardini, LA Brents, E Schröck, T Ried, WM Kuehl, ... Nature genetics 16 (3), 260-264, 1997 | 847 | 1997 |
| Clonal competition with alternating dominance in multiple myeloma JJ Keats, M Chesi, JB Egan, VM Garbitt, SE Palmer, E Braggio, ... Blood, The Journal of the American Society of Hematology 120 (5), 1067-1076, 2012 | 777 | 2012 |
| The t(4;14) Translocation in Myeloma Dysregulates Both FGFR3and a Novel Gene, MMSET, Resulting in IgH/MMSET Hybrid Transcripts M Chesi, E Nardini, RSC Lim, KD Smith, WM Kuehl, PL Bergsagel Blood, The Journal of the American Society of Hematology 92 (9), 3025-3034, 1998 | 697 | 1998 |
| Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma M Chesi, PL Bergsagel, OO Shonukan, ML Martelli, LA Brents, T Chen, ... Blood, The Journal of the American Society of Hematology 91 (12), 4457-4463, 1998 | 511 | 1998 |
| MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites H Pei, L Zhang, K Luo, Y Qin, M Chesi, F Fei, PL Bergsagel, L Wang, ... Nature 470 (7332), 124-128, 2011 | 486 | 2011 |
| Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma PL Bergsagel, M Chesi, E Nardini, LA Brents, SL Kirby, WM Kuehl Proceedings of the National Academy of Sciences 93 (24), 13931-13936, 1996 | 484 | 1996 |
| AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies M Chesi, DF Robbiani, M Sebag, WJ Chng, M Affer, R Tiedemann, ... Cancer cell 13 (2), 167-180, 2008 | 438 | 2008 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 434 | 2016 |
| Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma M Chesi, LA Brents, SA Ely, C Bais, DF Robbiani, EA Mesri, WM Kuehl, ... Blood, The Journal of the American Society of Hematology 97 (3), 729-736, 2001 | 385 | 2001 |
| Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines [see comments] M Chesi, PL Bergsagel, LA Brents, CM Smith, DS Gerhard, WM Kuehl | 381 | 1996 |
| Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma WJ Chng, GF Huang, TH Chung, SB Ng, N Gonzalez-Paz, T Troska-Price, ... Leukemia 25 (6), 1026-1035, 2011 | 308 | 2011 |
| Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma M Affer, M Chesi, WD Chen, JJ Keats, YN Demchenko, K Tamizhmani, ... Leukemia 28 (8), 1725-1735, 2014 | 271 | 2014 |
| Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy M Chesi, GM Matthews, VM Garbitt, SE Palmer, J Shortt, M Lefebure, ... Blood, The Journal of the American Society of Hematology 120 (2), 376-385, 2012 | 233 | 2012 |
| The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor J Marango, M Shimoyama, H Nishio, JA Meyer, DJ Min, A Sirulnik, ... Blood, The Journal of the American Society of Hematology 111 (6), 3145-3154, 2008 | 223 | 2008 |
| Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t (4; 14) myeloma S Trudel, S Ely, Y Farooqi, M Affer, DF Robbiani, M Chesi, PL Bergsagel Blood 103 (9), 3521-3528, 2004 | 215 | 2004 |
| Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis EE Plowright, Z Li, PL Bergsagel, M Chesi, DL Barber, DR Branch, ... Blood, The Journal of the American Society of Hematology 95 (3), 992-998, 2000 | 206 | 2000 |
Peter Leif BergsagelMayo Clinic in ArizonaVerified email at mayo.edu
